GTI-4711-201 GRECO-2: A Randomized, Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) in combination with GC4711
Clinical Trial Grant
Administered By
Radiation Oncology
Awarded By
Galera Therapeutics, Inc.
Start Date
June 23, 2021
End Date
February 19, 2024
Administered By
Radiation Oncology
Awarded By
Galera Therapeutics, Inc.
Start Date
June 23, 2021
End Date
February 19, 2024